Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies have shown that increased gut-derived norepinephrine (NE) release plays an important role in producing hepatocellular dysfunction at the early stage of
sepsis
. Although the gut has been demonstrated to be the major source of NE in
sepsis
, it remains unknown whether the increased NE is associated with up-regulation of intestinal NE biosynthesis enzymes such as tyrosine hydroxylase (TH) and
dopamine beta-hydroxylase
(
DBH
). To determine this, adult male rats were subjected to
sepsis
by cecal ligation and puncture (CLP) followed by fluid resuscitation. Small intestinal samples were harvested at 2 h (i.e., early
sepsis
) or 20 h (late
sepsis
) after CLP or sham-operation. Protein levels of TH and
DBH
were determined by Western blot analysis and immunohistochemistry. Their gene expression was assessed by RT-PCR technique. The results indicate that intestinal TH protein levels increased significantly at 2 and 20 h after CLP, while
DBH
was not altered under such conditions. Immunohistochemical examination shows that both TH and
DBH
were located in intestinal sympathetic nerve fibers and TH staining was markedly increased in septic animals. TH gene expression increased significantly at 2 h but not at 20 h after CLP, while
DBH
gene expression was not altered in
sepsis
. Thus, the increased TH gene and protein expression appears to be responsible for the increased gut-derived NE in
sepsis
.
...
PMID:Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase. 1527 47